
Global Gastrointestinal Stents Market Set to Surge to USD 815.34 Million by 2033 growth at a CAGR of 5.51%
Gastrointestinal cancer incidences in China were 14,934,040 cases of male and 6,262,431 cases of female with growth rate 181.44% in between 1990 to 2019.
NEWARK, DE, UNITED STATES, February 18, 2025 /EINPresswire.com/ -- The global gastrointestinal stents market is experiencing robust growth, with the latest industry analysis projecting it to reach USD 815.34 million by 2033, up from USD 476.72 million in 2023. This surge represents a compound annual growth rate (CAGR) of 5.51%, highlighting the increasing significance of gastrointestinal stents in addressing complex digestive disorders.
Gastrointestinal stents have become a critical component of modern healthcare, providing essential, minimally invasive solutions for patients suffering from gastrointestinal (GI) obstructions, strictures, cancers, and other conditions. As innovations in medical technology continue to evolve, the development of more efficient and effective stent devices is transforming patient care and enhancing treatment outcomes worldwide. These advancements not only improve the efficacy of GI treatments but also broaden the scope of therapeutic options available to patients and healthcare providers alike.
๐๐ข๐ฌ๐๐จ๐ฏ๐๐ซ ๐๐๐ซ๐ค๐๐ญ ๐๐ก๐ข๐๐ญ๐ฌ: ๐๐๐๐ฎ๐ซ๐ ๐๐จ๐ฎ๐ซ ๐๐๐ฆ๐ฉ๐ฅ๐ ๐๐๐ฉ๐จ๐ซ๐ญ ๐๐จ๐ฐ! https://www.futuremarketinsights.com/report-sample#5245502d47422d3134323935
๐๐ซ๐ข๐ฏ๐ข๐ง๐ ๐ ๐๐๐ญ๐จ๐ซ๐ฌ ๐ข๐ง ๐๐๐ซ๐ค๐๐ญ ๐๐ซ๐จ๐ฐ๐ญ๐ก: ๐๐ง๐ง๐จ๐ฏ๐๐ญ๐ข๐จ๐ง ๐๐ง๐ ๐๐ ๐ข๐ง๐ ๐๐จ๐ฉ๐ฎ๐ฅ๐๐ญ๐ข๐จ๐ง
Several factors contribute to the growth of the global gastrointestinal stent market. Technological breakthroughs in stent design and materials have enabled the creation of devices that better address patient needs while enhancing procedural safety and effectiveness.
Additionally, the global aging population and rising prevalence of GI disorders contribute significantly to increased demand for these medical devices. Gastrointestinal stents are proving indispensable in managing various GI disorders, improving patient quality of life, and offering healthcare providers reliable, patient-friendly solutions.
๐ ๐ฎ๐ญ๐ฎ๐ซ๐ ๐๐ฎ๐ญ๐ฅ๐จ๐จ๐ค: ๐๐ง ๐๐ง๐๐ข๐ฌ๐ฉ๐๐ง๐ฌ๐๐๐ฅ๐ ๐๐จ๐จ๐ฅ ๐ข๐ง ๐๐๐ญ๐ข๐๐ง๐ญ-๐๐๐ง๐ญ๐ซ๐ข๐ ๐๐๐ซ๐
Experts predict that the upward trajectory of the gastrointestinal stents market will continue over the next decade, fueled by ongoing advancements and a growing emphasis on patient-centered care. As healthcare systems worldwide prioritize minimally invasive solutions, the adoption of gastrointestinal stents is expected to further solidify their role in medical practice, providing patients with safer, more effective treatment options.
With the demand for gastrointestinal stents expected to rise, these devices remain pivotal in improving patient outcomes, enhancing treatment standards, and supporting the shift toward less invasive healthcare solutions. As a result, gastrointestinal stents will continue to be a critical tool for healthcare providers and an essential component of global healthcare innovation.
๐๐๐ฒ ๐๐๐ค๐๐๐ฐ๐๐ฒ๐ฌ
โข Due to the increasing prevalence of chronic liver disease and the increase in the number of surgical procedures for the treatment of biliary diseases, the biliary stents segment is likely to account for the largest gastrointestinal stents market share as per the product type.
โข Based on material, self-expanding metal stents are expected to lead the market. The same can be credited to benefits such as ease of insertion, a lower possibility of dislodgment or migration, and longer patency.
โข During the forecast period, the gastrointestinal cancers segment is anticipated to have the highest CAGR attributed to the increased prevalence and incidence, thereby positively impacting the gastrointestinal stents market trends.
โข The hospitals and clinics segment will be at the forefront of the market, owing to many endoscopic retrograde cholangiopancreatographies (ERCP) and percutaneous transhepatic cholangiography (PTC) procedures performed in hospitals for various disease indications.
โIn terms of market share and revenue, North America is predicted to dominate the gastrointestinal/GI stent market and will maintain its dominance throughout the forecast period on account of a sophisticated level of healthcare facilities, a rising geriatric population, high incidence of gastrointestinal diseases, favorable reimbursement scenario, and presence of key market players such as C.R. Bard (US), and Becton, Boston Scientific Corporation (US), Dickinson and Company.โ opines an FMI Analyst.
๐๐ฎ๐ซ๐ ๐ ๐ข๐ง ๐๐๐ซ๐ค๐๐ญ ๐๐๐ฆ๐๐ง๐: ๐๐ฑ๐ฉ๐ฅ๐จ๐ซ๐ ๐๐จ๐ฆ๐ฉ๐ซ๐๐ก๐๐ง๐ฌ๐ข๐ฏ๐ ๐๐ซ๐๐ง๐๐ฌ ๐๐ง๐ ๐๐ง๐๐ฅ๐ฒ๐ฌ๐ข๐ฌ ๐ข๐ง ๐๐ฎ๐ซ ๐ ๐ฎ๐ฅ๐ฅ ๐๐๐ฉ๐จ๐ซ๐ญ! https://www.futuremarketinsights.com/reports/gastrointestinal-stent-market
๐๐จ๐ฆ๐ฉ๐๐ญ๐ข๐ญ๐ข๐ฏ๐ ๐๐๐ง๐๐ฌ๐๐๐ฉ๐
๐ ๐๐๐๐ ๐๐๐พ ๐๐๐๐๐๐๐พ๐๐ ๐๐ ๐บ๐๐พ๐๐ ๐๐ ๐๐๐พ ๐ฆ๐จ, ๐๐๐พ๐๐๐ ๐๐บ๐๐๐พ๐ ๐บ๐๐พ
โข Boston Scientific Corporation
โข Hobbs Medical Inc.
โข Taewoong Medical
โข MicroโTech (Nanjing) Co., Ltd.
โข Olympus Corporation
โข Merit Medical Systems
โข Qualimed
โข Medtronic
โข Conmed Corporation
โข Terumo Corporation
โข Johnson & Johnson Services, Inc.
The gastrointestinal stent market is moderately competitive, with numerous gastrointestinal stents market opportunities. In addition, the increasing prevalence of diseases associated with gastrointestinal tract stent placement is driving up demand for gastrointestinal stents.
As a result, several global corporations are implementing various strategies to reach out to emerging economies such as product launches, mergers, acquisitions, partnerships, collaborations, etc.
๐๐จ๐ฆ๐ ๐จ๐ ๐ญ๐ก๐ ๐ซ๐๐๐๐ง๐ญ ๐๐๐ฏ๐๐ฅ๐จ๐ฉ๐ฆ๐๐ง๐ญ๐ฌ ๐ข๐ง ๐ญ๐ก๐ ๐ ๐๐ฌ๐ญ๐ซ๐จ๐ข๐ง๐ญ๐๐ฌ๐ญ๐ข๐ง๐๐ฅ ๐ฌ๐ญ๐๐ง๐ญ๐ฌ ๐ฆ๐๐ซ๐ค๐๐ญ ๐๐ซ๐
โข Cook Medical worked with Taewoong Medical to expand patient treatment options by distributing a variety of Taewoongโs stents in the United States. The Niti-STM Through the Scope (TTS) Esophageal Stent, the flagship product of the South Korean companyโs Niti-S Self-Expandable line of the metal gastrointestinal stent, is included in this distribution collaboration.
โข Olympus has proposed a couple of self-expanding metal stents (SEMS) to be used as palliative measures in patients with a short life expectancy or who have malignant colonic or duodenal obstruction.
๐๐๐ฏ๐๐ง๐ญ๐๐ ๐ ๐๐๐๐ฅ๐ญ๐ก๐๐๐ซ๐ ๐๐ง๐ฌ๐ข๐ ๐ก๐ญ๐ฌ ๐ญ๐จ ๐๐ฎ๐ญ๐ฉ๐๐๐ ๐๐จ๐ฆ๐ฉ๐๐ญ๐ข๐ญ๐จ๐ซ๐ฌ! https://www.futuremarketinsights.com/industry-analysis/therapeutic-device
๐๐๐ฒ ๐๐๐ซ๐ค๐๐ญ ๐๐๐ ๐ฆ๐๐ง๐ญ๐ฌ ๐๐จ๐ฏ๐๐ซ๐๐ ๐ข๐ง ๐๐๐ฌ๐ญ๐ซ๐จ๐ข๐ง๐ญ๐๐ฌ๐ญ๐ข๐ง๐๐ฅ ๐๐ญ๐๐ง๐ญ ๐๐ง๐๐ฎ๐ฌ๐ญ๐ซ๐ฒ ๐๐๐ฌ๐๐๐ซ๐๐ก
๐๐ฒ ๐๐ซ๐จ๐๐ฎ๐๐ญ:
โข Biliary Stents
โข Duodenal Stents
โข Colonic Stents
โข Pancreatic Stents
โข Esophageal Stents
๐๐ฒ ๐๐๐ญ๐๐ซ๐ข๐๐ฅ:
โข SelfโExpanding Metal Stents
โข Plastic Stents
๐๐ฒ ๐๐ฉ๐ฉ๐ฅ๐ข๐๐๐ญ๐ข๐จ๐ง:
โข Biliary Diseases
โข Irritable Bowel Syndrome
โข Gastrointestinal Cancers
โข Colorectal Cancer
โข Stomach Cancer
โข Esophageal Cancer
โข Pancreatic Cancer
๐๐ฒ ๐๐ง๐ ๐๐ฌ๐๐ซ:
โข Hospitals and Clinics
โข Ambulatory Surgical Centers
๐๐ฒ ๐๐๐ ๐ข๐จ๐ง:
โข North America
โข Latin America
โข Europe
โข East Asia
โข South Asia
โข Oceania
โข The Middle East and Africa (MEA)
๐๐ฑ๐ฉ๐ฅ๐จ๐ซ๐ ๐ ๐๐โ๐ฌ ๐๐๐ฅ๐๐ญ๐๐ ๐๐ง๐ ๐จ๐ข๐ง๐ ๐๐จ๐ฏ๐๐ซ๐๐ ๐ ๐จ๐ง ๐๐๐๐ฅ๐ญ๐ก๐๐๐ซ๐ ๐๐๐ซ๐ค๐๐ญ ๐๐ง๐ฌ๐ข๐ ๐ก๐ญ๐ฌ ๐๐จ๐ฆ๐๐ข๐ง:
๐ก๐ผ๐ป-๐ฉ๐ฎ๐๐ฐ๐๐น๐ฎ๐ฟ ๐ฆ๐๐ฒ๐ป๐๐ ๐ ๐ฎ๐ฟ๐ธ๐ฒ๐ ๐๐ฟ๐ผ๐๐๐ต โ ๐ง๐ฟ๐ฒ๐ป๐ฑ๐ & ๐๐ผ๐ฟ๐ฒ๐ฐ๐ฎ๐๐ ๐ฎ๐ฌ๐ฎ๐ฑ-๐ฎ๐ฌ๐ฏ๐ฑ: https://www.futuremarketinsights.com/reports/non-vascular-stents-market
๐๐ถ๐ผ๐ฎ๐ฏ๐๐ผ๐ฟ๐ฏ๐ฎ๐ฏ๐น๐ฒ ๐ฆ๐๐ฒ๐ป๐๐ ๐ ๐ฎ๐ฟ๐ธ๐ฒ๐ ๐ง๐ฟ๐ฒ๐ป๐ฑ๐ โ ๐๐ฟ๐ผ๐๐๐ต & ๐๐ผ๐ฟ๐ฒ๐ฐ๐ฎ๐๐ ๐ฎ๐ฌ๐ฎ๐ฏ-๐ฎ๐ฌ๐ฏ๐ฏ: https://www.futuremarketinsights.com/reports/bioabsorbable-stents-market
๐ฅ๐ฎ๐ฟ๐ฒ ๐๐ฎ๐๐๐ฟ๐ผ๐ถ๐ป๐๐ฒ๐๐๐ถ๐ป๐ฎ๐น ๐๐ถ๐๐ฒ๐ฎ๐๐ฒ๐ ๐ง๐ฟ๐ฒ๐ฎ๐๐บ๐ฒ๐ป๐ ๐ ๐ฎ๐ฟ๐ธ๐ฒ๐ ๐๐ฟ๐ผ๐๐๐ต โ ๐ง๐ฟ๐ฒ๐ป๐ฑ๐ & ๐๐ผ๐ฟ๐ฒ๐ฐ๐ฎ๐๐ ๐ฎ๐ฌ๐ฎ๐ฏ-๐ฎ๐ฌ๐ฏ๐ฏ: https://www.futuremarketinsights.com/reports/gastrointestinal-rare-diseases-treatment-market
๐ ๐ฎ๐ด๐ป๐ฒ๐๐ถ๐ฐ ๐ฅ๐ฒ๐๐ผ๐ป๐ฎ๐ป๐ฐ๐ฒ ๐๐บ๐ฎ๐ด๐ถ๐ป๐ด ๐๐ผ๐ถ๐น๐ ๐ ๐ฎ๐ฟ๐ธ๐ฒ๐ ๐๐ป๐ฎ๐น๐๐๐ถ๐ ๐ฏ๐ ๐ง๐๐ฝ๐ฒ ๐ถ๐ป๐๐ผ ๐ฅ๐ฎ๐ฑ๐ถ๐ผ๐ณ๐ฟ๐ฒ๐พ๐๐ฒ๐ป๐ฐ๐ ๐๐ผ๐ถ๐น ๐ฎ๐ป๐ฑ ๐๐ฟ๐ฎ๐ฑ๐ถ๐ฒ๐ป๐ ๐๐ผ๐ถ๐น ๐ง๐ต๐ฟ๐ผ๐๐ด๐ต ๐ฎ๐ฌ๐ฏ๐ฑ: https://www.futuremarketinsights.com/reports/magnetic-resonance-imaging-coils-market
๐๐ถ๐ฟ๐๐ต ๐ง๐ถ๐๐๐๐ฒ ๐ฃ๐ฟ๐ผ๐ฑ๐๐ฐ๐๐ ๐ ๐ฎ๐ฟ๐ธ๐ฒ๐ ๐๐ป๐ฎ๐น๐๐๐ถ๐ ๐ฏ๐ ๐๐ฝ๐ฝ๐น๐ถ๐ฐ๐ฎ๐๐ถ๐ผ๐ป ๐ถ๐ป๐๐ผ ๐๐ฎ๐ฟ๐ฑ๐ถ๐ผ๐๐ฎ๐๐ฐ๐๐น๐ฎ๐ฟ ๐๐ถ๐๐ผ๐ฟ๐ฑ๐ฒ๐ฟ๐, ๐ข๐ป๐ฐ๐ผ๐น๐ผ๐ด๐, ๐๐ฒ๐ฟ๐บ๐ฎ๐๐ผ๐น๐ผ๐ด๐, ๐ ๐๐๐ฐ๐๐น๐ผ๐๐ธ๐ฒ๐น๐ฒ๐๐ฎ๐น & ๐ข๐๐ต๐ฒ๐ฟ๐ ๐ง๐ต๐ฟ๐ผ๐๐ด๐ต ๐ฎ๐ฌ๐ฏ๐ฑ: https://www.futuremarketinsights.com/reports/birth-tissue-products-market
๐๐๐จ๐ฎ๐ญ ๐ ๐ฎ๐ญ๐ฎ๐ซ๐ ๐๐๐ซ๐ค๐๐ญ ๐๐ง๐ฌ๐ข๐ ๐ก๐ญ๐ฌ (๐ ๐๐)
Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.
๐๐จ๐ง๐ญ๐๐๐ญ ๐๐ฌ
Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware - 19713, USA
T: +1-347-918-3531
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube
Ankush Nikam
Future Market Insights, Inc.
+91 90966 84197
email us here
Visit us on social media:
Facebook
X
LinkedIn
YouTube

Distribution channels: Healthcare & Pharmaceuticals Industry
Legal Disclaimer:
EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.
Submit your press release